000 | 01757 a2200505 4500 | ||
---|---|---|---|
005 | 20250515125712.0 | ||
264 | 0 | _c20080821 | |
008 | 200808s 0 0 eng d | ||
022 | _a1473-5571 | ||
024 | 7 |
_a10.1097/QAD.0b013e328302cc11 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLehman, Dara A | |
245 | 0 | 0 |
_aHIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission. _h[electronic resource] |
260 |
_bAIDS (London, England) _cJul 2008 |
||
300 |
_a1475-85 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aCell-Free System _xvirology |
650 | 0 | 4 |
_aDNA, Viral _xanalysis |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _ximmunology |
650 | 0 | 4 |
_aHIV-1 _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfectious Disease Transmission, Vertical _xprevention & control |
650 | 0 | 4 |
_aMilk, Human _xvirology |
650 | 0 | 4 |
_aNevirapine _xtherapeutic use |
650 | 0 | 4 | _aPostpartum Period |
650 | 0 | 4 |
_aRNA, Viral _xanalysis |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aViral Load |
650 | 0 | 4 |
_aZidovudine _xtherapeutic use |
700 | 1 | _aChung, Michael H | |
700 | 1 | _aJohn-Stewart, Grace C | |
700 | 1 | _aRichardson, Barbra A | |
700 | 1 | _aKiarie, James | |
700 | 1 | _aKinuthia, John | |
700 | 1 | _aOverbaugh, Julie | |
773 | 0 |
_tAIDS (London, England) _gvol. 22 _gno. 12 _gp. 1475-85 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e328302cc11 _zAvailable from publisher's website |
999 |
_c18096411 _d18096411 |